Warning: The NCBI web site requires JavaScript to function. more...
Societal costs of air pollution-related health hazards: A review of methods and results.
Pervin T, Gerdtham UG, Lyttkens CH.
Cost Eff Resour Alloc. 2008 Sep 11;6:19.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C, Bojke L, Griffin S, Norman G, Barbieri M, Mather L, Stark D, Palmer S, Riemsma R.
Health Technol Assess. 2006 Mar;10(9):1-132. iii-iv. Review.
Generalisability in economic evaluation studies in healthcare: a review and case studies.
Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, Davies LM, Eastwood A.
Health Technol Assess. 2004 Dec;8(49):iii-iv, 1-192. Review.
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C, Brunskill S, Altman D, Briggs A, Campbell H, Clarke M, Glanville J, Gray A, Harris A, Johnston K, Lodge M.
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. Review.
[Meta-analysis of the Italian studies on short-term effects of air pollution].
Biggeri A, Bellini P, Terracini B; Italian MISA Group.
Epidemiol Prev. 2001 Mar-Apr;25(2 Suppl):1-71. Italian.
Air pollution and health: a European and North American approach (APHENA).
Katsouyanni K, Samet JM, Anderson HR, Atkinson R, Le Tertre A, Medina S, Samoli E, Touloumi G, Burnett RT, Krewski D, Ramsay T, Dominici F, Peng RD, Schwartz J, Zanobetti A; HEI Health Review Committee.
Res Rep Health Eff Inst. 2009 Oct;(142):5-90.
Depression: cost-of-illness studies in the international literature, a review.
Berto P, D'Ilario D, Ruffo P, Di Virgilio R, Rizzo F.
J Ment Health Policy Econ. 2000 Mar 1;3(1):3-10.
Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
Res Rep Health Eff Inst. 2009 Mar;(139):5-71; discussion 73-89.
Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.
Cruess AF, Zlateva G, Xu X, Soubrane G, Pauleikhoff D, Lotery A, Mones J, Buggage R, Schaefer C, Knight T, Goss TF.
Pharmacoeconomics. 2008;26(1):57-73.
Cost of depression in Europe.
Sobocki P, Jönsson B, Angst J, Rehnberg C.
J Ment Health Policy Econ. 2006 Jun;9(2):87-98.
How to develop cost-conscious guidelines.
Eccles M, Mason J.
Health Technol Assess. 2001;5(16):1-69. Review.
Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I, Coast J, Brown J.
Pediatrics. 2005 May;115(5):e600-14. Review.
Pharmaceutical policies: effects of cap and co-payment on rational drug use.
Austvoll-Dahlgren A, Aaserud M, Vist G, Ramsay C, Oxman AD, Sturm H, Kösters JP, Vernby A.
Cochrane Database Syst Rev. 2008 Jan 23;(1):CD007017. Review.
A systematic review of low back pain cost of illness studies in the United States and internationally.
Dagenais S, Caro J, Haldeman S.
Spine J. 2008 Jan-Feb;8(1):8-20. Review.
Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners.
Vassall A, Compernolle P.
Health Policy. 2006 Nov;79(1):1-15. Epub 2006 Jan 4. Review.
Cost-of-illness studies : a review of current methods.
Akobundu E, Ju J, Blatt L, Mullins CD.
Pharmacoeconomics. 2006;24(9):869-90. Review.
Comparison of conference abstracts and presentations with full-text articles in the health technology assessments of rapidly evolving technologies.
Dundar Y, Dodd S, Dickson R, Walley T, Haycox A, Williamson PR.
Health Technol Assess. 2006 Feb;10(5):iii-iv, ix-145. Review.
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.
Clegg A, Scott DA, Sidhu M, Hewitson P, Waugh N.
Health Technol Assess. 2001;5(32):1-195. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on